RL
CELUW icon

RPO LLC’s Celularity Inc CELUW Stock Holding History

RPO LLC’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-143,792
Closed -$8.63K – 86
2023
Q1 		$8.63K Sell
143,792
-235,634
-62% -$19.6K ﹤0.01% 127
2022
Q4 		$25K Hold
379,426
– – 0.01% 130
2022
Q3 		$147K Buy
379,426
+25,800
+7% +$11.2K 0.04% 167
2022
Q2 		$204K Buy
+353,626
New +$348K 0.05% 116

Other funds holding CELUW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

RPO LLC's CELUW Position: Q2 2023 in Review

RPO LLC sold out of Celularity Inc (CELUW) in Q2 2023, closing a stake of 143,792 shares — an estimated $8.63K sold.

RPO LLC first reported a position in CELUW in Q2 2022 and held it in 4 quarters. The position peaked at $204K in Q2 2022. 17 funds tracked by Wall St. Rank hold CELUW as of Q2 2023.

  • RPO LLC reported no remaining Celularity Inc position as of Q2 2023 after selling out during the quarter.
  • RPO LLC sold 143,792 Celularity Inc shares in Q2 2023, an estimated $8.63K.
  • RPO LLC first reported a position in Celularity Inc in Q2 2022 and held it in 4 quarters.
  • RPO LLC's Celularity Inc position peaked at $204K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2023.

Based on RPO LLC's 13F filing for Q2 2023, filed 9 Aug 2023.